Authors:
SORENSEN JM
VENA DA
FALLAVOLLITA A
CHUN HG
CHESON BD
Citation: Jm. Sorensen et al., TREATMENT OF REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA WITH FLUDARABINEPHOSPHATE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - 5-YEAR FOLLOW-UP REPORT, Journal of clinical oncology, 15(2), 1997, pp. 458-465
Authors:
MIKULSKI SM
CHUN HG
MITTELMAN A
PANELLA T
PUCCIO CA
SHOGEN K
COSTANZI JJ
Citation: Sm. Mikulski et al., RELATIONSHIP BETWEEN RESPONSE RATE AND MEDIAN SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF ONCONASE(R) WITHOTHER ANTICANCER AGENTS, International journal of oncology, 6(4), 1995, pp. 889-897
Authors:
CHUN HG
AHMED T
MITTELMAN A
NELSON J
FELDMAN E
LERNER R
Citation: Hg. Chun et al., PHASE-I TRIAL OF FLUDARABINE MONOPHOSPHATE (FAMP) PLUS ALPHA-INTERFERON (IFN-A) IN REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA (LGNHL), Blood, 86(10), 1995, pp. 3227-3227
Citation: Js. Roth et al., SIMULTANEOUS MEASUREMENT OF THE CELL-DIFFERENTIATING AGENT HEXAMETHYLENE BISACETAMIDE AND ITS METABOLITES BY GAS-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 652(2), 1994, pp. 149-159
Authors:
RAZIS E
ARLIN ZA
AHMED T
FELDMAN EJ
PUCCIO C
COOK P
CHUN HG
HELSON L
MITTELMAN A
Citation: E. Razis et al., INCIDENCE AND TREATMENT OF TUMOR LYSIS SYNDROME IN PATIENTS WITH ACUTE-LEUKEMIA, Acta haematologica, 91(4), 1994, pp. 171-174